ArticleAnnals of internal medicine2023

Recommended and Prevalent Use of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in a National Population-Based Sample.

Shichao Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.